Bio-Techne Corporation
TECH · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -9.6% | 0.2% | 6.4% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 66.4% | 62.7% | 67.9% | 65.3% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Income | $0 | -$0 | $0 | $0 |
| % Margin | 17.7% | -7.5% | 12.2% | 16% |
| Other Income/Exp. Net | -$0 | $0 | -$0 | -$0 |
| Pre-Tax Income | $0 | -$0 | $0 | $0 |
| Tax Expense | $0 | -$0 | $0 | $0 |
| Net Income | $0 | -$0 | $0 | $0 |
| % Margin | 13.3% | -5.6% | 7.1% | 11.7% |
| EPS | 0.25 | -0.11 | 0.14 | 0.22 |
| % Growth | 327.3% | -178.6% | -36.4% | – |
| EPS Diluted | 0.24 | -0.11 | 0.14 | 0.22 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 27.1% | 2% | 21.5% | 24.3% |